This kit is used to quantitatively detect the content of high-density lipoprotein cholesterol in human serum in vitro.
Background of Clinical Indications
It is used for the auxiliary diagnosis of cerebrovascular disease, diabetes, hepatitis and hepatic cirrhosis and other diseases. Increased: common in patients with primary hyperHDL (familial hyper-α-lipoproteinemia) and those receiving estrogen insulin or certain drugs (such as niacin, vitamin E, heparin, etc.); Decreased: common in patients with cerebrovascular disease, coronary heart disease, hypertriglyceridemia, and liver function damage. Its decrease can be used as a risk indicator of coronary heart disease.